A Study to know the effect of siddha medicine Irumal chooranam in the treatment of swasakaasam(Bronchial Asthma)

An open clinical trial to evaluate the effectiveness of siddha formulation Irumal chooranam in the management of swasakaasam (Bronchial Asthma) among patients reporting at ayothidoss pandithar hospital,National institute of siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071907

Enrollment

Registered

2024-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Irumal Chooranam: A Compound herbal drug powder indicated to treat bronchial asthma advised to intake 1.5 grams twice a day for 48 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient who are willing to undergo Pulmonary function test FEV1 between 50%- 80% will be taken. 2.Patients with clinical symptoms of Wheezing, Cough with or without expectoration,Dyspnea, Tightness of chest ,H/O Wheezing minimum 2 episodes per week.Any 2 or more symptoms will be included

Exclusion criteria

Exclusion criteria: 1.Having covid 19 or recent period of covid 19 infection 2.Restrictive Lung disease 3.Tuberculosis 4.Emphysema 5.Pleural effusion 6.Pneumothorax 7.Cardiac diseases 8.Renal diseases 9.Pregnancy and Lactation

Design outcomes

Primary

Measure	Time frame
Primary Outcome is assessed mainly by the values of pulmonary function test and improvement in the clinical signs and symptoms by asthma control questionnaire (ACQ) pre and post treatment.Timepoint: 48 days	—

Secondary

Measure	Time frame
Changes in laboratory parameters of IgE, Absolute Eosinophil Count(AEC), ESR pre and post treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr H NALINI SOFIA

National Institute of siddha

dr.h.nalinisofia@gmail.com8939899363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026